Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
- Conditions
- Uroepithelial Carcinoma
- Registration Number
- NCT06663735
- Brief Summary
A cross-sectional study describing the current status of diagnosis and treatment of uroepithelial cancer in hospitals of different grades in Henan Province
- Detailed Description
Patients diagnosed with uroepithelial carcinoma attending multiple research center hospitals in Henan Province from January 1, 2023 to December 31, 2023 A questionnaire was used to collect and analyze the treatment patterns of patients with early versus advanced uroepithelial cancer in different levels of hospitals in Henan Province.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 400
- Adults ≥18 years of age (at enrollment)
- Histologically confirmed uroepithelial carcinoma
- Patients with newly diagnosed or completed radical uroepithelial carcinoma in the early stages of uroepithelial cancer/advanced unresectable or with distant metastases of urothelial carcinoma
- Complete medical history information
- Incomplete medical history and medical records
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Describing the diagnosis and treatment patterns of patients with early versus advanced uroepithelial carcinoma in different grades of hospitals in Henan Province up to the patients enrolled,an average of 1 year To describe the similarities and differences between the way patients with early and advanced uroepithelial cancer are diagnosed and treated in different levels of hospitals in Henan Province and the current guidelines for uroepithelial cancer.
- Secondary Outcome Measures
Name Time Method Comparison of differences in diagnosis and treatment patterns between patients with early-stage and advanced uroepithelial carcinoma in county hospitals and different consultation departments of the same hospital in Henan province up to the patients enrolled,an average of 1 year The main purpose of this study is to compare the differences between the diagnosis and treatment modalities and guidelines for early and advanced uroepithelial cancer patients in Henan Province in county hospitals. It also compares the differences in treatment modalities between different departments in the same level of hospitals.
Describing the pathology as well as genetic testing of patients with uroepithelial carcinoma in different grades of hospitals in Henan province up to the patients enrolled,an average of 1 year 1. Proportion of different genes/proteins tested in patients with uroepithelial cancer (mutations in FGFR, HER2, HRR, ARID1A and CREBBP, TP53, CDKN2A and PD-L1 expression)
2. Proportion of early and advanced uroepithelial cancer patients with high expression/mutations of different genes and use of targeted therapies
Trial Locations
- Locations (11)
Kaifeng City Center Hospital
🇨🇳Kaifeng, Henan, China
Luoyang Renda Hospital
🇨🇳Luoyang, Henan, China
Nanyang City Center Hospital
🇨🇳Nanyang, Henan, China
Qingfeng County People's Hospital
🇨🇳Puyang, Henan, China
Department of Oncology
🇨🇳Xinxiang, Henan, China
Hui County People's Hospital
🇨🇳Xinxiang, Henan, China
Jun County People's Hospital
🇨🇳Xinxiang, Henan, China
Qi County People's Hospital
🇨🇳Xinxiang, Henan, China
Xinxiang Allied Hospital
🇨🇳Xinxiang, Henan, China
Xinxiang Central Hospital
🇨🇳Xinxiang, Henan, China
The First Affiliated Hospital of Zhengzhou University
🇨🇳Zhengzhou, Henan, China